Published in Vaccine Weekly, April 10th, 1995
According to Dr. Simons, "new therapies for prostate cancer are urgently needed. The metastatic disease inevitably becomes resistant to hormone therapy. In four decades, no chemotherapy or radiotherapy strategy has conferred survival improvement or cure for metastatic disease. Human gene therapy offers promise as a new systemic treatment for hormone refractory prostate cancer."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly